07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FDFA<br />

80432<br />

Stage V 18.0 years 89-457 *Puberty onset (transition from<br />

Tanner stage I to Tanner stage II) occurs<br />

for boys at a median age of 11.5 (+/-) 2<br />

years. For boys, there is no proven<br />

relationship between puberty onset and<br />

body weight or ethnic origin. Progression<br />

through Tanner stages is variable. Tanner<br />

stage V (adult) is usually reached by age<br />

18. 18-29 years: 89-457 mcg/dL 30-39<br />

years: 65-334 mcg/dL 40-49 years: 48-244<br />

mcg/dL 50-59 years: 35-179 mcg/dL > or<br />

=60 years: 25-131 mcg/dL FEMALES 1-14<br />

days: DHEA-S levels in newborns are very<br />

elevated at birth but fall to prepubertal<br />

levels within a few days. Tanner Stages*<br />

Mean Age Reference Range (mcg/dL)<br />

Stage I >14 days 16-96<br />

Stage II 10.5 years 22-184<br />

Stage III 11.6 years<br />

Stage IV 12.3 years 17-343<br />

Stage V 14.5 years 44-332 *Puberty onset (transition from<br />

Tanner stage I to Tanner stage II) occurs<br />

for girls at a median age of 10.5 (+/-) 2<br />

years. There is evidence that it may occur<br />

up to 1 year earlier in obese girls and in<br />

African American girls. Progression<br />

through Tanner stages is variable. Tanner<br />

stage V (adult) is usually reached by age<br />

18. 18-29 years: 44-332 mcg/dL 30-39<br />

years: 31-228 mcg/dL 40-49 years: 18-244<br />

mcg/dL 50-59 years: or =60 years:<br />

Clinical References: 1. Sciarra F, Tosti-Croce C, Toscano V: Androgen-secreting adrenal tumors.<br />

Minerva Endocrinol 1995;20:63-68 2. Young WF Jr: Management approaches to adrenal<br />

incidentalomas-a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000;21:671-696 3.<br />

Ibanez L, DiMartino-Nardi J, Potau N, Saenger P: Premature adrenarche-normal variant or forerunner of<br />

adult disease? Endocrine Reviews 2001;40:1-16 4. Collett-Solberg P: Congenital adrenal hyperplasia:<br />

from genetics and biochemistry to clinical practice, part I. Clin Pediatr 2001;40:1-16 5. Allolio B, Arlt W:<br />

DHEA treatment: myth or reality? Trends Endocrinol Metab 2002;13:288-294 6. Salek FS, Bigos KL,<br />

Kroboth PD: The influence of hormones and pharmaceutical agents on DHEA and DHEA-S<br />

concentrations: a review of clinical studies. J Clin Pharmacol 2002;42:247-266 7. Elmlinger MW, Kuhnel<br />

W, Ranke MB: Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol<br />

(E2), prolactin, progesterone, sex hormone binding globulin (SHBG), dehydroepiandrosterone sulfate<br />

(DHEA-S), cortisol and ferritin in neonates, children, and young adults. Clin Chem Lab Med<br />

2002;40(11):1151-1160 8. Package insert: IMMUNLITE 2000 DHEA-SO(4) [PIL2KDS-7;002-04-08]<br />

Diagnostics Products Corporation<br />

Dengue Fever Antibodies (IgG, IgM)<br />

Reference Values:<br />

Reference Range: IgG

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!